rs114242958
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001292063.2(OTOG):c.7535G>A(p.Arg2512His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00606 in 1,428,630 control chromosomes in the GnomAD database, including 422 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.7535G>A | p.Arg2512His | missense_variant | 45/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.7571G>A | p.Arg2524His | missense_variant | 44/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.7535G>A | p.Arg2512His | missense_variant | 45/56 | 5 | NM_001292063.2 | ENSP00000382329.2 | ||
OTOG | ENST00000399391.7 | c.7571G>A | p.Arg2524His | missense_variant | 44/55 | 5 | ENSP00000382323.2 | |||
OTOG | ENST00000342528.2 | n.4606-712G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0313 AC: 4541AN: 145236Hom.: 233 Cov.: 31
GnomAD3 exomes AF: 0.00590 AC: 862AN: 146140Hom.: 37 AF XY: 0.00476 AC XY: 376AN XY: 78932
GnomAD4 exome AF: 0.00320 AC: 4112AN: 1283242Hom.: 189 Cov.: 34 AF XY: 0.00277 AC XY: 1752AN XY: 631794
GnomAD4 genome AF: 0.0313 AC: 4544AN: 145388Hom.: 233 Cov.: 31 AF XY: 0.0302 AC XY: 2141AN XY: 70790
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 31, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Arg2524His in exon 44 of OTOG: This variant is not expected to have clinical sig nificance because it has been identified in 13.6% (24/176) of Yoruba (Nigerian) chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi .nlm.nih.gov/projects/SNP; dbSNP rs114242958). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at